In rNK cells from NASH, we found GZMK and the inhibitory receptor CD96 were upregulated, while cNK cells overexpressed the chemokines CCL3 and CCL4, the activation marker CD69, and the chemokine receptor CXCR4. The gene discussed is GZMK; the disease is metabolic dysfunction-associated steatohepatitis.